[opensourcepharma] Marburg Meeting and Open Source Pharma Items

Wed Sep 9 12:04:10 UTC 2015

I think these links should be posted on the open-source pharma website. b

On Sat, Sep 5, 2015 at 3:35 AM, Matthew Todd <mattoddchem at gmail.com> wrote:

> All,
>
> The 2nd Open Source Pharma Meeting just closed here in Germany. Follow-up
> action and coordination items will be coming to the participants (derived
> from the raw notes <http://tinyurl.com/OSP2Final>). For everyone else you
> can see some of the activity at the meeting on the OSP Twitter feed
> <https://twitter.com/OSPInfo>. In what must be a speed record, one of the
> participants, Andy Updegrove, has already posted an informative blog post
> <http://www.consortiuminfo.org/standardsblog/article.php?story=20150904123645851>
> on the meeting intended for people unfamiliar with the concept.
>
> Other items:
>
> 1. Repurposing for schistosomiasis
> <http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0003962>
> from DNDi and Jenny Keiser
>
> 2. An analysis
> <http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0134898>
> of how people respond to prize-based science competitions (here,
> Innocentive): "women and older participants have significantly less fear of
> disclosing their scientific knowledge"
>
> 3. A new offering from Lilly
> <https://openinnovation.lilly.com/dd/what-we-offer/synthesis.html> for
> collaborations in automated synthesis that might be useful for a number of
> projects.
>
> 4. An article
> <https://www.jisc.ac.uk/blog/open-science-many-hands-make-light-work-17-aug-2015>
> on the importance of open science to the forthcoming Dutch presidency of
> the EU.
>
> 5. Collaboration
> <http://www.thesgc.org/news/toronto/ontario-institute-cancer-research-and-structural-genomics-consortium-develop-and-give>
> between the SGC and the Ontario Institute for Cancer Research on OICR-9429.
>
> 6. For the software people: a debate
> <https://danielskatzblog.wordpress.com/2015/08/27/the-price-of-open-source-software-a-joint-response/>
> about how we should develop software for science, e.g. whether open source
> and whether it should be free.
>
> 7. A company I wasn't aware of, Transcriptic
> <https://www.transcriptic.com/product/>, that is doing remote, "dial-in"
> life science experiments.
>
> 8. Community cooperation in a website to track the quality and clarify the
> function (and hence the correct use) of chemical probes. Paper
> <http://www.nature.com/nchembio/journal/v11/n8/full/nchembio.1867.html>, article
> from ICR
> <http://www.icr.ac.uk/blogs/the-drug-discoverer/page-details/ensuring-biomedical-research-is-gold-standard-through-better-use-of-chemical-probes>.
>
>
> 9. Article <http://www.nature.com/nrd/journal/v14/n9/full/nrd4706.html>
> about the CO-ADD antibiotic screening facility in Queensland.
>
> 10. Using the SGC as an example, a study
> <http://www.sciencedirect.com/science/article/pii/S0048733314002248> on
> how "boundary organisations" can help companies deal with open data
> initiatives.
>
> 11. In case you missed it the Economist going to town on patents (here
> <http://www.economist.com/news/leaders/21660522-ideas-fuel-economy-todays-patent-systems-are-rotten-way-rewarding-them-time-fix>,
> here <http://www.economist.com/node/21660559>) and Derek Lowe's take
> <http://blogs.sciencemag.org/pipeline/archives/2015/08/13/the-problem-with-patents>.
> Article
> <http://www.bioprocessonline.com/doc/rare-diseases-and-intellectual-property-creative-ip-strategies-0001>
> from the Rare Genomics Institute on creative IP policies.
>
> 12. A recent paper
> <http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2641815> on An
> International Legal Framework to Address Antimicrobial Resistance
>
> 13. A collection of US doctors advocating
> <http://www.mayoclinicproceedings.org/article/S0025-6196%2815%2900430-9/fulltext>
> for lower cancer drug prices.
>
> A very tentative save the date. There are suggestions we might hold a 3rd
> Open Source Pharma meeting at the end of September 2016 in Silicon Valley.
> If anyone has any particular positive or negative views on that (and
> possible host locations that can compete with Lake Como or a German castle)
> then please let me know.
>
> Many of us are in Basel this coming week for ECTMIH - there is an
> interesting session
> <http://www.professionalabstracts.com/ectmih2015/planner/index.php?go=cp&sessID=72>
> on open source at 1:30 on Monday 7th.
>
> A reminder, particularly given that several people have recently signed
> up: this email list is available for anyone to share items of interest or
> to start overview discussions related to open source approaches to pharma.
> Please work on the principle that we all already receive too many emails
> (i.e. this list is not a chatroom), and please remember that the archive of
> all mails sent is public.
>
> Best wishes everyone,
>
> Mat
>
>
> --
> MATTHEW TODD | Associate Professor
> School of Chemistry | Faculty of Science
>
> THE UNIVERSITY OF SYDNEY
> Rm 519, F11 | The University of Sydney | NSW | 2006
> T +61 2 9351 2180  | F +61 2 9351 3329  | M +61 415 274104
> E matthew.todd at sydney.edu.au | W
> http://sydney.edu.au/science/people/matthew.todd.php
> W http://opensourcemalaria.org/ | W http://opensourcetb.org/ | W
> http://opensourcepharma.net/
>
> CRICOS 00026A
> This email plus any attachments to it are confidential. Any unauthorised
> use is strictly prohibited. If you receive this email in error, please
> delete it and any attachments.
>
> _______________________________________________
> opensourcepharma mailing list
> opensourcepharma at lists.okfn.org
> https://lists.okfn.org/mailman/listinfo/opensourcepharma
>
>

-- 
Follow me on Forbes <http://blogs.forbes.com/bernardmunos/> and Fastercures
<http://fastercures.tumblr.com/post/62722481036/give-me-your-innovators-yearning-to-breathe-free#!>
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.okfn.org/pipermail/opensourcepharma/attachments/20150909/accbd7e1/attachment-0002.html>